Allocca M - Search Results

1

The role of filgotinib in ulcerative colitis and Crohn's disease.

Fanizza J, D'Amico F, Lauri G, Martinez-Dominguez SJ, Allocca M, Furfaro F, Zilli A, Fiorino G, Parigi TL, Radice S, Peyrin-Biroulet L, Danese S. Fanizza J, et al. Among authors: allocca m. Immunotherapy. 2024 Feb;16(2):59-74. doi: 10.2217/imt-2023-0116. Epub 2023 Nov 27. Immunotherapy. 2024. PMID: 38009327 Review.

2

Commentary: antibodies reacting with the infliximab Fab portion--something new?

Allocca M, Fiorino G, Danese S. Allocca M, et al. Aliment Pharmacol Ther. 2013 Sep;38(5):552. doi: 10.1111/apt.12401. Aliment Pharmacol Ther. 2013. PMID: 23937461 Free article. No abstract available.

3

Cross-sectional imaging modalities in Crohn's disease.

Allocca M, Fiorino G, Danese S. Allocca M, et al. Dig Dis. 2013;31(2):199-201. doi: 10.1159/000353692. Epub 2013 Sep 6. Dig Dis. 2013. PMID: 24030225 Review.

4

Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target.

Allocca M, Jovani M, Fiorino G, Schreiber S, Danese S. Allocca M, et al. Curr Drug Targets. 2013 Nov;14(12):1508-21. doi: 10.2174/13894501113146660224. Curr Drug Targets. 2013. PMID: 24102406 Review.

5

Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation.

Fiorino G, Allocca M, Danese S. Fiorino G, et al. Among authors: allocca m. Aliment Pharmacol Ther. 2014 Jan;39(2):227-8. doi: 10.1111/apt.12578. Aliment Pharmacol Ther. 2014. PMID: 24330239 Free article. No abstract available.

6

Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

Gilardi D, Fiorino G, Genua M, Allocca M, Danese S. Gilardi D, et al. Among authors: allocca m. Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):835-46. doi: 10.1586/17474124.2014.917954. Epub 2014 May 12. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24813226 Review.

7

Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target.

Allocca M, Fiorino G, Vermeire S, Reinisch W, Cataldi F, Danese S. Allocca M, et al. Expert Rev Clin Immunol. 2014 Jul;10(7):885-95. doi: 10.1586/1744666X.2014.917962. Epub 2014 May 12. Expert Rev Clin Immunol. 2014. PMID: 24813675 Review.

8

Review article: optimal preparation for surgery in Crohn's disease.

Spinelli A, Allocca M, Jovani M, Danese S. Spinelli A, et al. Among authors: allocca m. Aliment Pharmacol Ther. 2014 Nov;40(9):1009-22. doi: 10.1111/apt.12947. Epub 2014 Sep 10. Aliment Pharmacol Ther. 2014. PMID: 25209947 Free article. Review.

9

Iron deficiency: the hidden miscreant in inflammatory bowel disease.

Allocca M, Fiorino G, Danese S. Allocca M, et al. Curr Drug Targets. 2014;15(11):1011-9. doi: 10.2174/1389450115666140909150850. Curr Drug Targets. 2014. PMID: 25213175 Review.

10

New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease.

Bravatà I, Fiorino G, Allocca M, Repici A, Danese S. Bravatà I, et al. Among authors: allocca m. Scand J Gastroenterol. 2015 Jan;50(1):113-20. doi: 10.3109/00365521.2014.993700. Scand J Gastroenterol. 2015. PMID: 25523561 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page